Proliferative diabetic retinopathy and non-proliferative diabetic retinopathy are stages of diabetic retinopathy. The former is the more severe form that can lead to vision loss. Unmanaged diabetes ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Specialists can identify subtle changes in the retina before symptoms appear and apply treatments that can slow or stop vision loss. Ophthalmologists specialize in the diagnosis and treatment of ...

The diabetic retinopathy severity scale (DRSS) is a 13-step scale. Healthcare professionals can use the DRSS to measure the severity of diabetic retinopathy in people with diabetes. Diabetic ...

Medically reviewed by Danielle Weiss, MD Key Takeaways Diabetes occurs in four stages: insulin resistance, prediabetes, type ...

In patients with nonproliferative diabetic retinopathy who underwent cataract surgery, yttrium aluminum garnet (YAG) laser capsulotomy was associated with increased risks for progression of the ...

Fundus photography involves taking a photo of the back of the eye to detect signs of diabetic retinopathy. It is also possible to capture an image of the retina using a smartphone. Diabetic ...

Some reassuring news for patients taking GLP-1 receptor agonists: Concerns that the drugs may cause retinopathy may be overblown. A new analysis of nearly 160,000 people with diabetes taking four ...

This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...

Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1 ...

Oculis Holding (OCS) lost more than 20% on Friday after the company announced the failure of two late-stage trials assessing its lead candidate, OCS-01, for diabetic macular edema, a serious eye ...